Chicago, Illinois
United States
5
2022-03-03
2
2020-11-17
These are the the leading inventors for applications assigned to Exicure, Inc.:
Exicure, Inc. based in Chicago, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
SPHERICAL NUCLEIC ACID TLR9 AGONISTS
#2 | 2021-09-02IL-1 BETA TARGETING SPHERICAL NUCLEIC ACIDS
#3 | 2021-04-08SPHERICAL NUCLEIC ACID-BASED CONSTRUCTS AS IMMUNOSTIMULATORY AGENTS FOR PROPHYLACTIC AND THERAPEUTIC USE
#4 | 2018-11-08 ✅ Patent 10,837,018 granted on 2020-11-17Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
#5 | 2016-06-30 ✅ Patent 10,894,963 granted on 2021-01-19Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
Also check out Exicure, Inc.'s (Chicago, United States) applicant profile with 2 patent applications submitted.
309259 ⎘